+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Chemiluminescence Immunoassay"

From
From
From
Immunoassay Systems: Global Strategic Business Report - Product Thumbnail Image

Immunoassay Systems: Global Strategic Business Report

  • Report
  • April 2024
  • 267 Pages
  • Global
From
C-Reactive Protein Testing - Global Strategic Business Report - Product Thumbnail Image

C-Reactive Protein Testing - Global Strategic Business Report

  • Report
  • April 2024
  • 174 Pages
  • Global
From
Immunodiagnostics Global Market Report 2024 - Product Thumbnail Image

Immunodiagnostics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator

The Chemiluminescence Immunoassay (CLIA) market is a segment of the In Vitro Diagnostics (IVD) industry. CLIA is a type of immunoassay that uses a chemical reaction to detect the presence of a specific antigen or antibody in a sample. CLIA tests are used to diagnose a wide range of medical conditions, including infectious diseases, autoimmune disorders, and cancer. CLIA tests are highly sensitive and specific, and can be used to detect very low levels of antigens or antibodies in a sample. CLIA tests are used in a variety of healthcare settings, including hospitals, clinics, and laboratories. CLIA tests are also used in research and development, as well as in the food and beverage industry. CLIA tests are becoming increasingly popular due to their accuracy and cost-effectiveness. Some companies in the CLIA market include Abbott Laboratories, Beckman Coulter, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more